Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response

Background: Anakinra (ANA) is an effective treatment choice in patients with adult onset Still’s disease (AOSD). Variables affecting treatment survival include loss of efficacy or adverse events, but also the decision to discontinue treatment after long-term clinical remission. Objectives: Aims of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Antonio, Cavalli, Giulio, Colafrancesco, Serena, Priori, Roberta, Valesini, Guido, Argolini, Lorenza Maria, Baldissera, Elena, Bartoloni, Elena, Cammelli, Daniele, Canestrari, Giovanni, Sota, Jurgen, Cavallaro, Elena, Massaro, Maria Grazia, Ruscitti, Piero, Cipriani, Paola, De Marchi, Ginevra, De Vita, Salvatore, Emmi, Giacomo, Ferraccioli, Gianfranco, Frassi, Micol, Gerli, Roberto, Gremese, Elisa, Iannone, Florenzo, Lapadula, Giovanni, Lopalco, Giuseppe, Manna, Raffaele, Mathieu, Alessandro, Montecucco, Carlomaurizio, Mosca, Marta, Piazza, Ilaria, Piga, Matteo, Pontikaki, Irene, Romano, Micol, Rossi, Silvia, Rossini, Maurizio, Silvestri, Elena, Stagnaro, Chiara, Talarico, Rosaria, Tincani, Angela, Viapiana, Ombretta, Vitiello, Gianfranco, Galozzi, Paola, Sfriso, Paolo, Gaggiano, Carla, Rigante, Donato, Dagna, Lorenzo, Giacomelli, Roberto, Cantarini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454864/
https://www.ncbi.nlm.nih.gov/pubmed/31001115
http://dx.doi.org/10.3389/fphar.2019.00296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454864/
https://www.ncbi.nlm.nih.gov/pubmed/31001115
http://dx.doi.org/10.3389/fphar.2019.00296

Ejemplares similares